Home > EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine).

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe. (4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

[img] PDF (Report on a new psychoactive substance: 25I-NBOMe) - Published Version
2MB

The EMCDDA–Europol Joint Report on new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine, commonly known by the abbreviation ‘25I-NBOMe’, submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that sufficient information had been accumulated to merit the production of a Joint Report on 25I-NBOMe as stipulated by Article 5.1 of the Decision.

The following street names have been reported: ‘25I’, ‘dots’, ‘legal acid’, ‘NBomb’,‘NE-BOME’, ‘smiles’, ‘INBMeO’, ‘BOM-CI’, ‘Hoffman’ and ‘N-boom’.


Date:January 2014
Pages:33 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction & EUROPOL
Corporate Creators:Europol, European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page